Submission of course post tests is temporarily unavailable. Thank you for your patience as we work toward a solution. For immediate help, please contact ONS Help Desk.

Oncology Drug Reference Sheet: Tarlatamab-Dlle

By: Kristine B. LeFebvre, DNP, RN, NPD-BC, AOCN®

Published In: Voice

Publication Date: 2024-08-27

Description

Tarlatamab-dlle (Imdelltra^™) was granted accelerated approval in May 2024 for the treatment of extensive-stage small cell lung cancer with progression on or after a platinum chemotherapy regimen.

View Article @ voice.ons.org

ONS Drug Education

Short summaries of newly approved oncology-related therapies or drugs with new indications.

View All Drug Education

Oncology Drug Reference Sheet: Tarlatamab-Dlle

Description

ONS Drug Education

Related Topics